Cyclic dinucleotides, such as c-di-GMP, c-di-AMP, and cGAMP, have come to the forefront of both chemical and biological investigations because they are involved in important signal transduction processes in both eukaryotes and prokaryotes. 1 The intracellular concentrations of these second messengers uctuate in response to changing environments, leading to the activation and/or repression of various cellular processes.
1
Cyclic dinucleotides are synthesized from two molecules of purine triphosphates by synthases and their actions are terminated upon degradation by hydrolyases. 2 The synthase for c-di-GMP is diguanylate cyclase (DGC), which is characterized by a GGDEF domain, 3 whereas c-di-AMP is synthesized from ATP by diadenylate cyclase (DAC), characterized by a DisA_N domain. 4 cGAMP, containing a non-canonical 2 0 ,5 0 -phosphodiester linkage, is synthesized by cyclic GMP-AMP synthase (cGAS) in response to duplex DNA in the cytoplasm of immune cells of higher organisms.
5 Both c-di-GMP and c-di-AMP are broken down into 5 0 -phosphoguanylyl/adenylyl-(3 0 -5 0 )-guanosine/adenosine (pGpG or pApA) and further into GMP or AMP, by phosphodiesterases (PDEs). 6 C-di-GMP PDE-A (containing EAL domain) cleaves c-di-GMP in pGpG 7 and further into GMP by PDE-B 8 whereas PDEs containing the HD-GYP domain cleave c-di-GMP directly into GMP. 9 Similarly, whereas some c-di-AMP PDEs cleave the cyclic dinucleotide to linear pApA, others can cleave into AMP. [10] [11] [12] Recently it was revealed that oligoribonuclease (Orn), which had earlier been established as an essential enzyme in most bacteria involved in the recycling of RNA into ribonucleotides 13, 14 acts as c-di-GMP PDB-B in Pseudomonas aeruginosa. 8, 15 PDEs are now emerging as key regulators of bacterial tness and virulence, [14] [15] [16] [17] [18] and some could become potential antibacterial drug targets.
There is however a paucity of inhibitors that target cyclic dinucleotide signaling [16] [17] [18] [19] and no clinical drug is as yet in development for inhibiting cyclic dinucleotide signaling, but the case is different with signaling by cyclic mononucleotides such as cGMP 20 and cAMP, 21 which were identied in 1960s. For example, Sildenal (Viagra®), a cGMP PDE5 inhibitor, is used to treat erectile dysfunction. 22 There are also a handful of cyclic mononucleotide-related PDE inhibitors, such as GSK256066 (PDE4 inhibitor) 23 and Milrinone (Primacor®, PDE3 inhibitor), 24 which are currently in clinical use for the treatment of pulmonary hypertension and cardiovascular diseases. The successful identication of cyclic mononucleotide-related PDE inhibitors, such as Sildenal, was facilitated by assays that could be used in high throughput manner to monitor the enzymatic cleavage of cGMP or cAMP by PDEs. [25] [26] [27] Analogously, colorimetric or uorimetric assays that could be used to monitor the cleavage of cyclic or linear dinucleotide in a high throughput manner would also facilitate the identication of inhibitors of cyclic dinucleotide metabolism enzymes. Thus far, cyclic dinucleotide detection methods, such as HPLC-MS, 28 radiolabeled ribozyme 29 or Spinach RNA, 30 uorescent or colorimetric intercalator assays [31] [32] [33] [34] [35] and ELISA, 36 have been reported. However these methods, albeit sensitive, have a few drawbacks. For example, the HPLC-MS method is not amenable for high throughput assays or real-time monitoring or is expensive to implement. The riboswitch method is also expensive to utilize in a high throughput way, notwithstanding the difficulty of working with RNA and some of the intercalator assays (such as the thiazole orange assay) 31 require overnight incubation and hence not ideal for real-time monitoring. Others have also used p-nitrophenyl phosphate (pNPP) to monitor cyclic dinucleotide PDE activity 37, 38 but three limitations of this substrate are: (a) pNPP is not a good substrate for many cyclic dinucleotide PDEs or Orns; (b) background hydrolysis (PDEindependent cleavage) of pNPP is high and (c) the colorimetric readout of the cleavage product, para nitrophenol, overlaps with many compounds that are found in chemical libraries used for screening.
Fluorogenic analogs of cyclic dinucleotides are potential probes for proling PDE activity. Fluorescent nucleobase analogs have been used in several applications, [39] [40] [41] [42] including the study of nucleic acid dynamics 43 and structure. 44 Several assays that are used to monitor nucleic acid processing enzymes have incorporated a uorescent nucleobase into the nucleotide or oligonucleotide substrate. 42 In general, uorescent nucleobases can be categorized into ve classes, namely (1) extended nucleobases; (2) conjugated base analogs; (3) purine analogs; (4) aromatic and chromophoric base analogs and (5) isomorphic base analogs 45 (see Fig. 1 ). 2-Aminopurine (2-AP) and ethenoadenosine (ethenoA) are two widely utilized uorescent nucleobases and are commercially available.
46,47
2-AP is considered as "isomorphic" uorescent nucleobase and closely resembles adenine. In fact it can form strong base pairs with thymine and uracil. 46, 47 As far back as 1969, Ward et al. showed that the uorescence emission of 2-AP is reduced when placed within an oligonucleotide. 48 Later, others demonstrated that the nature of the neighboring nucleobase also affected the uorescence prole of 2-AP. 47 EthenoA was developed by Secrist to study adenosine-containing coenzymes.
49
Both the excitation (345 nm) and emission (435 nm) of ethenoA are more red shied than those of 2-AP (ex. ¼ 310 nm and em. ¼ 375 nm), and this is due to the extended pi-system of etheno. Consequently, ethenoA is more suitable for biological assays than 2-AP as it suffers less from interference of biological uorophores.
41,42
Chatterji et al. 50 and the group of Banin 15 reported that the uorescence of MANT-c-di-GMP (see Fig. 2 ), slightly decreased upon cleavage by RocR, 15 a c-di-GMP PDE that we have been interested in developing inhibitors against. 19 However, MANT-cdi-GMP has a bulky uorophore group appended to 2 0 -position of c-di-GMP and this steric block could account for the poor substrate prole for some PDEs. We recently reported that the replacement of one of the native nucleobases of c-di-GMP with 2-AP afforded a uorescent analog (compound 1, Fig. 2 ) that could be used to monitor the activity of PDEs. 33 Motivated by our initial success in developing a uorescent probe that can monitor PDE activity we decided to develop a palette of uo-rescent dinucleotide probes that could complement MANT-c-di-GMP. For the AP probes, we proceeded to investigate how the nature of the second nucleotide (adenine vs. guanine) in the 2-AP probe affected the uorescence response to PDE cleavage (compare compound 1 vs. compound 2). Additionally, we explored other uorescent nucleobases, such as etheno analog 3 and 4, hoping to increase the repertoire of uorescent analogs of cyclic dinucleotides, which could facilitate high throughput screening for PDE inhibitors (Fig. 2) . Also, in this new study we have explored uorescent linear dinucleotides (compounds 5 and 6) as activity probes for oligoribonucleases.
We rst prepared the uorescent probes 2 to 4 following Jones' strategy outlined in Scheme 1.
51 For this strategy one portion of guanosine or adenosine phosphoramidite was rst converted into H-phosphonate, followed by the coupling with another portion of deoxyribose 2-AP or ribose etheno phosphoramidite to achieve the linear dimer 13. The cyclization reagent 5,5-dimethyl-2-oxo-2-chloro-1,3,2-dioxaphosphinane (DMOCP), was used to convert the linear dimer 13 into a cyclized form 14 in the same ask. Aer deprotecting all of the protecting groups on the nucleobase exocyclic amine and 2 0 -OH, the crude product was subjected to HPLC purication. The uorescent linear dinucleotides (5 and 6) were synthesized on solid support as shown in Scheme 2, using a DNA synthesizer. With these new uorescent probes in hand, we then proceeded to test if they were cyclic dinucleotide PDE substrates and if so, whether the uorescence of these probes changed upon PDE cleavage. The uorescence of cyclic probes (compounds 1 to 4) is quenched via electron transfer between adenine (A) or guanine (G) to the uorescent base (see Fig. 3 , S1 and S2 †).
52,53 Upon cleavage by PDE-A, the resulting linear form is less constrained, with more options of projecting the positions of the uorescent base and A or G base. Compared to the parent cyclic probes, the distance between uorescent and A/G base could be more, or less than or about the same as the distance in cyclic probes (see Fig. 3 ). Thus, overall uorescence change upon cleavage of PDE-A could be either "turn-on" or "turn-off". Upon PDE-B or oligoribonuclease cleavage, the resulting mononucleotides are far from each other (see Fig. 3 , X 4 \ X 1 , X 2 and X 3 ), and therefore a uorescence turn-on is expected. Similarly, when the cyclic probes are cleaved with SVPD (a control promiscuous phosphodiesterase that cleaves most cyclic and linear di-or polynucleotides into mononucleotides), a uorescence turn-on would be expected (see Fig. 3 ).
We incubated compounds 1 and 2 with RocR and YybT. RocR is c-di-GMP PDE, containing EAL domain, and was rst identied in P. aeruginosa. 54 RocR breaks down c-di-GMP rst into linear form pGpG and then into GMP. 54 On the other hand, YybT, a c-di-AMP PDE, is able to cleave c-di-AMP into its linear form, 5 0 -pApA.
10
We therefore expected RocR to cleave compound 1 better than compound 2 and YybT to cleave 2 better than 1 due to the preferences of RocR and YybT for guanine-containing and adenine-containing cyclic dinucleotides respectively. Upon cleavage by RocR, both compounds 1 and 2 showed decrease in uorescence (Fig. 4) but compound 1 showed a greater uorescence decrease, conrming our expectation that RocR would prefer the guanine-containing probe. Compound 1 was cleaved as fast as the natural substrate, c-di-GMP (see Fig. S3 †) . Similarly, YybT also cleaved both compounds 1 and 2, resulting in a decrease in uorescence (Fig. 4) . In contrast to RocR, the magnitude of uorescence decrease upon cleavage of compound 2 (adenine-containing) by YybT was larger than upon cleavage of compound 1 (guaninecontaining) by YybT. Here too this was expected because YybT preferentially cleaves c-di-AMP over c-di-GMP. 10 The degree of cleavage of compound 2 (10 mM) by YybT (1 mM) was similar to the cleavage of c-di-AMP by YybT (see Fig. S4 †) . Of note, as stated, upon cleavage by RocR or YybT, the linearized probes showed lower uorescence than the cyclized form. As proposed in Fig. 3 , the distance between uorescent and normal base aer cleavage by RocR or YybT would change (see Fig. 3 ) and the decrease in uorescence upon cleavage implies that the proportion of conformers whereby the nucleobases are close enough for photoelectron transfer is higher in the linear dinucleotide than in the cyclized form. To ascertain if these cyclic probes (compounds 1 to 4) could be used for high throughput screening assays, we investigated if a known inhibitor of RocR or YybT could affect the uorescence of the assays. We therefore chose EDTA as it chelates divalent metals that are essential for the PDE activity (Mg 2+ for RocR and Mn 2+ for YybT). We also chose a known inhibitor of RocR as a second control. Upon cleavage of compound 1 by RocR in the presence of EDTA, the uorescence intensity decreased by only 20% (versus 60% without EDTA) (Fig. 4A) . Also, in the presence of a RocR benzoisothiazolinone inhibitor, 19 the change in uorescence intensity was minimal (see Fig. 4A ). The same trend was observed for the cleavage of compound 2 by YybT. Upon cleavage of compound 2 by YybT in the presence of EDTA, the uorescence intensity decreased by only 10% (versus 50% without EDTA) (Fig. 4B) . The uorescence of the cyclic ethenoA analogs, compounds 3 and 4, are too low (guanine or adenine seem to efficiently quench the uorescence of etheno adenine in both the cyclic and linear dinucleotide) to be used as activity probe for PDE-A (see ESI, Fig. S2 †) but these probes were useful for monitoring PDE-B or Orn activity, vide infra.
PDE-B or Orn cleave linear dinucleotides into mononucleotides. As shown in Fig. 3 , the distance between the nucleobases becomes greatest upon PDE-B or Orn cleavage (compared to the distances in the cyclic or linear dinucleotides). Therefore we expected that dinucleotides containing either 2-AP or etheno adenine would be excellent turn-on probes for monitoring the activities of PDE-B or Orn. To conrm our hypothesis, we incubated linear probes (compounds 5 and 6) with different Orns (E. coli, P. aeruginosa and M. smegmatis Orns) (see Fig. 5 ). Upon cleavage of compounds 5 and 6 by all three different Orns, an increase in uorescence intensity was observed (Fig. 5) . To conrm that the increase in uorescence was due to the enzymatic cleavage of the compounds, we again performed the enzymatic reactions in the presence of 50 mM EDTA, which would inhibit the enzymatic cleavage. As expected, there was no change in uorescence intensity with the linear probes (compounds 5 and 6) when EDTA was present. Compound 5 gave the highest fold change in uorescence. E. coli Orn cleaved compound 5 as well as the natural pGpG (see Fig. S5 †) and we recommend 5 as the ideal substrate to screen for inhibitors of oligoribonuclease or to assay the activity of Orns.
Conclusion
In summary, we disclose new uorescent linear and cyclic dinucleotide probes, which could facilitate cyclic dinucleotide PDE research and drug discovery. Recently several reports have documented the roles of cyclic dinucleotide (c-di-GMP, c-di-AMP and cGAMP) phosphodiesterases in bacterial virulence 1 as well in innate immunity (cleavage of 2 0 3 0 -cGAMP) and probes, 55, 56 such as the ones reported in this manuscript could be used to conrm the activity of expressed PDE enzymes or used to screen for inhibitors of dinucleotide phosphodiesterases. 19, 57 
